Data extracted from this reference:
Cloned(Commentary)
Mycobacterium tuberculosis
Crystallization (Commentary)
structures of the C-terminal domain of FbiB in apo-, F420-0-, and FMN-bound states, displaying distinct sites for F420-0 and FMN ligands that partially overlap
Mycobacterium tuberculosis
Organism
Mycobacterium tuberculosis
P9WP79
cf. EC 6.3.2.31, EC 6.3.2.34
Mycobacterium tuberculosis H37Rv
P9WP79
cf. EC 6.3.2.31, EC 6.3.2.34
Cloned(Commentary) (protein specific)
Mycobacterium tuberculosis
Crystallization (Commentary) (protein specific)
structures of the C-terminal domain of FbiB in apo-, F420-0-, and FMN-bound states, displaying distinct sites for F420-0 and FMN ligands that partially overlap
Mycobacterium tuberculosis
General Information
physiological function
FbiB produces cofactor F420 with predominantly 5-7 L-glutamate residues in the poly-gamma-glutamate tail, reactions of EC 6.3.2.31 and 6.3.2.34. The N-terminal domain of FbiB is homologous to CofE with an annotated gamma-glutamyl ligase activity, whereas the C-terminal domain has sequence similarity to an FMN-dependent family of nitroreductase enzymes. Communication between the two domains is critical for full gamma-glutamyl ligase activity
Mycobacterium tuberculosis
General Information (protein specific)
physiological function
FbiB produces cofactor F420 with predominantly 5-7 L-glutamate residues in the poly-gamma-glutamate tail, reactions of EC 6.3.2.31 and 6.3.2.34. The N-terminal domain of FbiB is homologous to CofE with an annotated gamma-glutamyl ligase activity, whereas the C-terminal domain has sequence similarity to an FMN-dependent family of nitroreductase enzymes. Communication between the two domains is critical for full gamma-glutamyl ligase activity
Mycobacterium tuberculosis
Other publictions for EC 1.3.8.17
760400
Braga
Redox coenzyme F420 biosynthe ...
Thermomicrobium roseum
Appl. Environ. Microbiol.
86
e00457
2020
-
-
1
-
-
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
1
-
1
-
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
-
-
1
1
-
-
-
757742
Bashiri
A revised biosynthetic pathwa ...
Mycolicibacterium smegmatis, Mycolicibacterium smegmatis ATCC 700084
Nat. Commun.
10
1558
2019
-
-
-
1
-
-
-
-
-
-
-
-
-
3
-
-
-
-
-
-
-
-
2
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
2
-
-
-
-
-
-
-
-
-
-
1
1
-
-
-
760607
Ayikpoe
Spectroscopic and electrochem ...
Mycobacterium ulcerans, Mycobacterium ulcerans Agy99
Biochemistry
58
940-950
2019
-
-
-
-
8
-
-
-
-
-
-
-
-
4
-
-
-
-
-
-
-
-
4
-
2
-
-
-
-
-
-
-
2
-
-
-
-
-
-
2
-
8
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
4
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
745359
Bashiri
Elongation of the poly-gamma- ...
Mycobacterium tuberculosis, Mycobacterium tuberculosis H37Rv
J. Biol. Chem.
291
6882-6894
2016
-
-
1
1
-
-
-
-
-
-
-
-
-
2
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1
-
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1
1
-
-
-
761374
Choi
Use of transposon Tn5367 muta ...
Mycobacterium tuberculosis variant bovis, Mycobacterium tuberculosis variant bovis ATCC BAA-935
J. Bacteriol.
183
7058-7066
2001
-
-
-
-
-
-
-
-
-
-
-
-
-
2
-
-
-
-
-
-
-
-
-
-
3
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1
1
-
-
-